rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Aurobindo Pharma Ltd.

524804 AUROPHARMA Group (A)

03 Sep,15:52
1549.60
-3.60 (-0.23%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Aurobindo Pharma Ltd.

BUYSELL
4,943 1,553.20 1,569.05 - 1,546.25 1,582.00 - 815.15 90,791.07
NSE | BSE

Aurobindo Pharma Ltd.

AUROPHARMA

03 Sep,15:59
1549.40
-4.55 (-0.29%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Aurobindo Pharma Ltd.

BUYSELL
1,033,542 1553.95 1,569.80 - 1,546.40 1,584.45 - 815.80 1,607,715,922.68

News for Aurobindo Pharma Ltd.

Aurobindo,...
Aurobindo, Glenmark, FDC Recall Drugs in US: USFDA
Aurobindo, Glenmark, and FDC are recalling drugs in the US due to manufacturing issues, according to the USFDA. The recalls include pain relief medication, Indomethacin capsules, and Timolol...
Aug 26, 2024 19:01
USFDA Issues...
USFDA Issues Warning Letter to Eugia Pharma for Manufacturing Lapses
USFDA has issued a warning letter to Eugia Pharma, a subsidiary of Aurobindo Pharma, for manufacturing lapses at its Hyderabad plant, citing data accuracy and process simulation issues.
Aug 25, 2024 13:25
Aurobindo Pharma...
Aurobindo Pharma China Plant to Start Production in Q3 FY25
Aurobindo Pharma's China facility to start production in Q3 FY25, with full-scale output in FY26. The company also expects its Pen-G plant to ramp up production significantly.
Aug 19, 2024 12:24
Aurobindo Pharma...
Aurobindo Pharma Gets USFDA Warning for Telangana Unit
Aurobindo Pharma's Eugia Pharma Specialities Ltd received a warning letter from the USFDA for its formulations manufacturing unit in Telangana. The company assures no impact on existing US supplies.
Aug 16, 2024 11:29
Aurobindo Pharma Q1 Profit Surges 61% to Rs 919 Cr
Aurobindo Pharma's net profit for Q1 FY25 jumped 61% to Rs 919 crore driven by strong sales. Revenue also grew to Rs 7,567 crore.
Aug 10, 2024 20:08

More News for Aurobindo Pharma Ltd. »

(Rs. Crore)

Financial Results of Aurobindo Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales10,645.6412,792.2811,287.1415,823.6813,266.48
Operating profit2,224.041,730.921,473.404,119.822,685.75
Interest182.60114.9816.9428.6895.58
Gross profit2,657.502,049.702,127.454,681.002,848.18
EPS (Rs)33.3521.0024.8353.1331.96

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Aurobindo Pharma Ltd.

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer. Wikipedia

News for Pharmaceuticals and health care

Microsoft &...
Microsoft & Karnataka Partner for Generative AI Skilling - Minister Patil
Microsoft plans to sign an MoU with Karnataka to enhance skills in Generative AI and other emerging technologies, as announced by Minister M B Patil.
Sep 03, 2024 22:27
Raymond Lifestyle...
Raymond Lifestyle to Add 900 Outlets in 3 Years - Stock Listing on Sep 5
Raymond Lifestyle will be listed on the stock exchanges on September 5 and plans to add 900 new outlets in three years. The company aims for 15% CAGR in the men's-wear wedding market.
Sep 03, 2024 22:12
Climate-Smart...
Climate-Smart Agri Financing: Challenges & Solutions in India
Report highlights obstacles to climate-smart agriculture financing in India, including risk perception, lack of incentives and unclear guidelines. Solutions include dedicated funds, blended finance...
Sep 03, 2024 22:08
AirKerala.com...
AirKerala.com Appoints Harish Moideen Kutty as CEO
AirKerala.com, the upcoming ultra low-cost carrier by Zett Fly Aviation, has appointed Harish Moideen Kutty as CEO. Kutty brings extensive experience from carriers like SpiceJet and SalamAir.
Sep 03, 2024 21:51
India Held to...
India Held to Draw by Mauritius in Intercontinental Cup
India's Intercontinental Cup campaign started with a disappointing goalless draw against Mauritius. Despite dominating possession, India failed to find the net, leaving fans disappointed.
Sep 03, 2024 21:42

More News »

Top News

Microsoft &...
Microsoft & Karnataka Partner for Generative AI Skilling - Minister Patil
Microsoft plans to sign an MoU with Karnataka to enhance skills in Generative AI and other emerging technologies, as announced by Minister M B Patil.
Sep 03, 2024 22:27
Raymond Lifestyle...
Raymond Lifestyle to Add 900 Outlets in 3 Years - Stock Listing on Sep 5
Raymond Lifestyle will be listed on the stock exchanges on September 5 and plans to add 900 new outlets in three years. The company aims for 15% CAGR in the men's-wear wedding market.
Sep 03, 2024 22:12
Climate-Smart...
Climate-Smart Agri Financing: Challenges & Solutions in India
Report highlights obstacles to climate-smart agriculture financing in India, including risk perception, lack of incentives and unclear guidelines. Solutions include dedicated funds, blended finance...
Sep 03, 2024 22:08
Infopark IT Exports Surge 24.28% in 2023-24
Infopark, Kerala's IT hub, reports a record 24.28% growth in exports, reaching Rs 11,417 crore in 2023-24, driven by pandemic-induced digitization.
Sep 03, 2024 21:55
AirKerala.com...
AirKerala.com Appoints Harish Moideen Kutty as CEO
AirKerala.com, the upcoming ultra low-cost carrier by Zett Fly Aviation, has appointed Harish Moideen Kutty as CEO. Kutty brings extensive experience from carriers like SpiceJet and SalamAir.
Sep 03, 2024 21:51

More Top News »

Report Card

PE Ratios
46.41
EPS (Rs.)
33.35
Sales (Rs. Cr)
2,460.09
Face Value (Rs.)
1
Net Profit Margin (%)
18.35
Last Bonus
1:1
Last Dividend(%)
150
Return on Average Equity
9.9

BSE Announcements from Aurobindo Pharma Ltd. (See all)

announcement Shareholder Meeting / Postal Ballot-Scrutinizer''s Report - 4 day(s) ago
announcement Shareholder Meeting / Postal Ballot-Outcome of AGM - 5 day(s) ago

Compare 'Aurobindo Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,820.75
  • Compare
  • Divi's Laboratories Ltd.
  • 5,093.40
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,488.70
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 7,029.20
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,128.30
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,928.80
  • Compare
  • Max Healthcare Institute Ltd.
  • 864.25
  • Compare
  • Alkem Laboratories Ltd.
  • 6,167.80
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

Sir, i have opted for epf pension from 60 yr of age,...

Hi Vivek! My wife and I have some mutual funds to...

My father(51M) wants to buy flat worth(48L,...

My husband is 50 and I am 47. We have a combined...

I was running a bussiness from last seven year with...

Sir My age is 53. My PF contribution from salary is...

More REDIFFGURUS

RediffGurus

Money question

Sir, as the government has introduced the UPS, which...

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Aurobindo Pharma Ltd.
Share Price » Fundamentals » Financial » Technicals » Option Chain » Screener » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close